EMG
BMRN icon

Ellington Management Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Ellington Management Group’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-9,300
Closed -$786K – 84
2020
Q1 		$786K Buy
9,300
+5,600
+151% +$483K 0.18% 153
2019
Q4 		$313K Buy
+3,700
New +$279K 0.07% 294
2019
Q3 		– Sell
-6,100
Closed -$522K – 602
2019
Q2 		$522K Buy
+6,100
New +$522K 0.09% 227
2019
Q1 		– Sell
-2,600
Closed -$221K – 564
2018
Q4 		$221K Buy
+2,600
New +$247K 0.07% 281
2018
Q1 		– Sell
-8,400
Closed -$749K – 821
2017
Q4 		$749K Buy
+8,400
New +$730K 0.12% 134
2014
Q1 		– Sell
-4,000
Closed -$281K – 609
2013
Q4 		$281K Buy
+4,000
New +$272K 0.1% 337

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return